Verona Pharma plc

VRNA Healthcare
$106.91 +$0.12 (0.11%)
Market Cap: $9.21 B
Gurus Holding
6
Popularity Rank
#1240
% of Shares Held
3.17%
Net Activity (Q3 2025)
+$108.2 M

Guru Ownership Trend

Guru Analysis for Verona Pharma plc (VRNA)

Verona Pharma plc (VRNA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $291.98 M.

Top institutional holders include Stanley Druckenmiller and Renaissance Technologies.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $108.2 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies who increased their stake by 317.8%.

Portfolio Manager % Portfolio Activity Shares Value Report Date
2.63% 1,002,080 $106.93 M Q3 2025
0.09% Add 317.8% 615,900 $65.72 M Q3 2025
0.07% New Buy 400,000 $42.68 M Q3 2025
0.43% New Buy 285,185 $30.43 M Q3 2025
0.08% New Buy 264,115 $28.18 M Q3 2025
0.17% New Buy 163,800 $17.48 M Q3 2025

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q3 2025)

+$168.77 M
Total Buy Value
New Buys 4
Additions 1
-$60.57 M
Total Sell Value
Reductions 0
Sold Out 2

Guru Consensus (Q3 2025)

Based on recent activity
Net Sellers
2
Net Buyers
5

FAQs for Verona Pharma plc (VRNA)

Top Guru holders include Stanley Druckenmiller ($106.93 M), Renaissance Technologies ($65.72 M), Paul Tudor Jones ($42.68 M). Collectively, tracked Gurus hold 2.73 M shares.

Based on recent 13F filings, the sentiment is Positive (Net Buy). There was a net inflow of $108.2 M, with 5 Gurus buying and 2 Gurus selling.

In the recent quarter, 0 Gurus reduced their positions, and 2 Gurus sold out of VRNA completely. Total sell value was $60.57 M.

Yes, 4 Gurus opened new positions in VRNA, and 1 added to their existing holdings. Total buy value was $168.77 M.